Monod Bio and SignalChem Biotech Forge Licensing Deal for AI-Designed Proteins
August 26, 2026 — Monod Bio and SignalChem Biotech sign licensing agreement to integrate AI-designed LuxSit luciferase and NovoBodies into custom assay services, accelerating drug discovery.